ProAir Respiclick (albuterol sulfate inhalation powder) / Teva - LARVOL DELTA

"آلبوترول دارویی است که باعث باز شدن مجاری تنفسی می‌شود. این دارو تحت برندهای دیگری نیز به بازار عرضه می‌شود که نام های دیگر آن عبارتند از: ProAir HFA, ProAir RespiClick, Proventil HFA, Ventolin HFA..از وجود انسولین قلمی در داروخانه‌ّا اطمینان حاصل کنید@merck #blurrywyesight" (@alidoki1)

Teva Reports First Quarter 2021 Financial Results (Businesswire) - "ProAir (HFA and RespiClick) revenues in our North America segment in the first quarter of 2021 decreased by 9% to $54 million, compared to the first quarter of 2020. In January 2019, we launched our own ProAir authorized generic in the United States, following the launch of a generic version of Ventolin® HFA, another albuterol inhaler. Revenues from our ProAir authorized generic are included in 'generic products' above."

Sales • Asthma • Chronic Obstructive Pulmonary Disease • Respiratory Diseases

Teva Reports Fourth Quarter and Full Year 2020 Financial Results (Businesswire) - "Generic products revenues in our North America segment in the fourth quarter of 2020 increased by 6% to $1,206 million...mainly due to new generic product launches, higher revenues from TRUXIMA (the biosimilar to Rituxan®) and our ProAir authorized generic...ProAir (HFA and RespiClick) revenues in our North America segment in the fourth quarter of 2020 decreased by 17% to $67 million...Revenues from our ProAir authorized generic are included in 'generic products'..."

Sales • Asthma • Chronic Obstructive Pulmonary Disease • Respiratory Diseases

Drugs for COPD. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • Chronic Obstructive Pulmonary Disease • Infectious Disease • Tobacco Cessation

Comparison table: Inhaled short-acting bronchodilators for treatment of COPD. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • Chronic Obstructive Pulmonary Disease

Table: Correct Use of inhalers for COPD. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • Asthma • Chronic Obstructive Pulmonary Disease • Respiratory Diseases

COVID-19 And COPD: What Is The Effect? COVID-19 And COPD: What Is Important? - "How Does COVID-19 Affect COPD? Age (65 years or older), COPD, along with other medical conditions are risk factors for developing serious illness, including respiratory failure and death, if infected with SARS-CoV-2....How to Protect Yourself from Getting COVID-19? The SARS-CoV-2 is thought to spread mainly from person to person. Thus, the best way to prevent illness is to avoid being exposed to the coronavirus."

Online posting • Chronic Obstructive Pulmonary Disease